[1] |
李勇, 路丽苹, 李瑾, 等. 上海市松江区肺结核患者耐药特征及耐多药结核病影响因素分析. 结核与肺部疾病杂志, 2022, 3(2): 142-147. doi:10.19983/j.issn.2096-8493.20210109.
doi: 10.19983/j.issn.2096-8493.20210109
|
[2] |
Kizito E, Musaazi J, Mutesasira K, et al. Risk factors for mortality among patients diagnosed with multi-drug resistant tuberculosis in Uganda-a case-control study. BMC Infect Dis, 2021, 21(1): 292. doi:10.1186/s12879-021-05967-2.
doi: 10.1186/s12879-021-05967-2
pmid: 33752637
|
[3] |
Caminero Luna JA, Pérez Mendoza G, Rodríguez de Castro F. Multi-drug resistant tuberculosis, ten years later. Med Clin (Barc), 2021, 156(8): 393-401. doi:10.1016/j.medcli.2020.08.018.
doi: 10.1016/j.medcli.2020.08.018
URL
|
[4] |
World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020.
|
[5] |
World Health Organization. Global tuberculosis report 2021. Geneva: World Health Organization, 2021.
|
[6] |
Tiberi S, Zumla A, Migliori GB. Multidrug and Extensively Drug-resistant Tuberculosis: Epidemiology, Clinical Features, Management and Treatment. Infect Dis Clin North Am, 2019, 33(4): 1063-1085. doi:10.1016/j.idc.2019.09.002.
doi: 10.1016/j.idc.2019.09.002
URL
|
[7] |
李艳, 林鹏, 王晔, 等. 广东省2000—2013年艾滋病监测结果分析. 华南预防医学, 2015, 41(2): 101-106. doi:10.13217/j.scjpm.2015.0101.
doi: 10.13217/j.scjpm.2015.0101
|
[8] |
中华人民共和国国家卫生和计划生育委员会. WS 196—2017结核病分类. 2017-11-09.
|
[9] |
Ruan YZ, Li RZ, Wang XX, et al. The affordability for patients of a new universal MDR-TB coverage model in China. Int J Tuberc Lung Dis, 2016, 20(5): 638-644. doi:10.5588/ijtld.15.0413.
doi: 10.5588/ijtld.15.0413
pmid: 27084818
|
[10] |
Muniyandi M, Thomas BE, Karikalan N, et al. Association of Tuberculosis With Household Catastrophic Expenditure in South India. JAMA Netw Open, 2020, 3(2): e1920973. doi:10.1001/jamanetworkopen.2019.20973.
doi: 10.1001/jamanetworkopen.2019.20973
|
[11] |
张广川. 广州市耐多药肺结核经济负担及影响因素分析. 广州: 广东药科大学, 2021.
|
[12] |
王宇. 耐多药肺结核防治管理. 北京: 军事医学科学出版社, 2012.
|
[13] |
中国经济社会大数据研究平台. 统计年鉴[EB/OL]. [2022-06-10]. https://data.cnki.net/Yearbook/Navi?type=type&code=A.
|
[14] |
World Health Organization. Protocol for survey to determine direct and indirect costs due to TB and to estimate proportion of TB-affected households experiencing catastrophic total costs due to TB. Geneva: World Health Organization, 2015.
|
[15] |
Hwang JS, Hu TH, Lee LJ, et al. Estimating lifetime medical costs from censored claims data. Health Econ, 2017, 26(12): e332-e344. doi:10.1002/hec.3512.
doi: 10.1002/hec
|
[16] |
闫赟. 中国5城市耐多药肺结核患者诊治及管理现状研究. 济南: 山东大学, 2010.
|
[17] |
Wang Y, McNeil EB, Huang Z, et al. Household financial burden among multidrug-resistant tuberculosis patients in Guizhou province, China: A cross-sectional study. Medicine (Baltimore), 2020, 99(28): e21023. doi:10.1097/MD.0000000000021023.
doi: 10.1097/MD.0000000000021023
|
[18] |
边学峰. 中国耐多药结核病防治体系现状、问题与对策研究. 济南: 山东大学, 2011.
|
[19] |
陈丽金, 周颖, 钟云, 等. 广东省耐多药结核病患者疾病经济负担研究. 中国卫生经济, 2021, 40(3): 72-75.
|
[20] |
王倩, 张修磊, 阴佳. 山东省耐多药肺结核患者医疗费用灾难性支出分析研究. 河南预防医学杂志, 2020, 31(12): 918-920. doi:10.13515/j.cnki.hnjpm.1006-8414.2020.12.013.
doi: 10.13515/j.cnki.hnjpm.1006-8414.2020.12.013
|
[21] |
张加胜. 耐多药肺结核患者的医疗费用、经济负担及补偿现状. 济南: 山东大学, 2011.
|
[22] |
Gamtesa DF, Tola HH, Mehamed Z, et al. Health care seeking behavior among presumptive tuberculosis patients in Ethiopia: a systematic review and meta-analysis. BMC Health Serv Res, 2020, 20(1): 445. doi:10.1186/s12913-020-05284-5.
doi: 10.1186/s12913-020-05284-5
pmid: 32429988
|
[23] |
Uplekar M, Weil D, Lonnroth K, et al. WHO’s new end TB strategy. Lancet, 2015, 385(9979): 1799-1801. doi:10.1016/S0140-6736(15)60570-0.
doi: S0140-6736(15)60570-0
pmid: 25814376
|